S. 3014: Ensuring Timely Access to Generics Act of 2025

S. 3014 is a federal bill in the 119th Congress. Before this bill, brand name drug companies could file formal requests called citizen petitions with the Food and Drug Administration to question or delay the approval of competing generic drugs, often doing so at strategic times without strict time limits… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.